Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Arkis Biosciences

JPM 2021: Conformis Announces ACS Knee For 2H 2021, Integra Weathers Pandemic

The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the final day of the meeting.

Orthopedics Financing

AZ-Pfizer relief: 'at risk' partnerships in the clear as takeover plans fold

As the news breaks that UK big pharma AstraZeneca has rejected a final takeover bid from US giant Pfizer, several of both the firms' smaller pharma and biotech partners will be breathing a sigh of relief.

Cancer Switzerland

AZ-Pfizer side effects: Partnership crossover casualties coming soon?

As the Pfizer, AstraZeneca megamerger circus continues following meetings between UK government committees and both companies' chiefs executives (, 15 May 2014), Scrip has been investigating possible repercussions a takeover could have on the giant drug makers' smaller pharma and biotech partners.

Cancer Switzerland
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices